[go: up one dir, main page]

NO970036L - New oral pharmaceutical preparation containing magnesium salt of omeprazole - Google Patents

New oral pharmaceutical preparation containing magnesium salt of omeprazole

Info

Publication number
NO970036L
NO970036L NO970036A NO970036A NO970036L NO 970036 L NO970036 L NO 970036L NO 970036 A NO970036 A NO 970036A NO 970036 A NO970036 A NO 970036A NO 970036 L NO970036 L NO 970036L
Authority
NO
Norway
Prior art keywords
omeprazole
magnesium salt
oral pharmaceutical
pharmaceutical preparation
preparation containing
Prior art date
Application number
NO970036A
Other languages
Norwegian (no)
Other versions
NO970036D0 (en
Inventor
Siv Inga Bengtsson
Kurt Ingmar Loevgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO970036L publication Critical patent/NO970036L/en
Publication of NO970036D0 publication Critical patent/NO970036D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nytt, oralt farmasøytisk preparat iiuieholdende en ny fysisk form av et magnesiumsalt av omeprazol belagt med et eller flere enteriske belegglag, en fremgangsmåte for fremstilling av et slikt preparat, anvendelsen av et slikt preparat i medisinen og en blærepakning inneholdende det nye preparatet.A new oral pharmaceutical composition comprising a new physical form of a magnesium salt of omeprazole coated with one or more enteric coating layers, a process for preparing such a preparation, the use of such a preparation in medicine and a bladder pack containing the new preparation.

NO970036A 1994-07-08 1997-01-06 New oral pharmaceutical preparation containing magnesium salt of omeprazole NO970036D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400679 1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en) 1994-07-08 1995-07-03 New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (2)

Publication Number Publication Date
NO970036L true NO970036L (en) 1997-01-06
NO970036D0 NO970036D0 (en) 1997-01-06

Family

ID=20393105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970036A NO970036D0 (en) 1994-07-08 1997-01-06 New oral pharmaceutical preparation containing magnesium salt of omeprazole

Country Status (15)

Country Link
EP (1) EP0768872A1 (en)
KR (1) KR970704426A (en)
BR (1) BR9508261A (en)
CA (1) CA2193681A1 (en)
CZ (1) CZ379596A3 (en)
EE (1) EE03378B1 (en)
FI (1) FI970058A0 (en)
HU (1) HUT78132A (en)
IS (1) IS4398A (en)
MX (1) MX9700152A (en)
NO (1) NO970036D0 (en)
NZ (1) NZ289958A (en)
PL (1) PL181265B1 (en)
SK (1) SK281803B6 (en)
WO (1) WO1996001622A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5900258A (en) * 1996-02-01 1999-05-04 Zeolitics Inc. Anti-bacterial compositions
SI9700186B (en) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Novel pharmaceutical preparation with controlled release of active healing substances
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704870D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9802973D0 (en) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1133987A1 (en) * 2000-03-09 2001-09-19 Ian Whitcroft Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
EP1263445A1 (en) * 2000-03-09 2002-12-11 Ian Whitcroft Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570796A1 (en) * 2004-06-15 2006-01-05 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of benzimidazole compounds
CN105106168B (en) * 2015-08-19 2018-03-06 德州德药制药有限公司 A kind of esomeprazole magnesium intestines capsule and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (en) * 1988-05-18 1995-07-26 エーザイ株式会社 Oral formulation of acid labile compounds
SE9302396D0 (en) * 1993-07-09 1993-07-09 Ab Astra A NOVEL COMPOUND FORM
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION

Also Published As

Publication number Publication date
WO1996001622A1 (en) 1996-01-25
AU2994795A (en) 1996-02-09
WO1996001622A8 (en) 1999-12-23
FI970058L (en) 1997-01-07
NO970036D0 (en) 1997-01-06
SK166096A3 (en) 1997-09-10
KR970704426A (en) 1997-09-06
SK281803B6 (en) 2001-08-06
BR9508261A (en) 1997-12-23
PL318464A1 (en) 1997-06-09
MX9700152A (en) 1997-04-30
CZ379596A3 (en) 1997-08-13
CA2193681A1 (en) 1996-01-25
HU9700039D0 (en) 1997-02-28
AU695723B2 (en) 1998-08-20
IS4398A (en) 1996-12-17
EE03378B1 (en) 2001-04-16
FI970058A7 (en) 1997-01-07
FI970058A0 (en) 1997-01-07
EE9700014A (en) 1997-06-16
NZ289958A (en) 1998-09-24
EP0768872A1 (en) 1997-04-23
PL181265B1 (en) 2001-06-29
HUT78132A (en) 2000-06-28

Similar Documents

Publication Publication Date Title
NO970036L (en) New oral pharmaceutical preparation containing magnesium salt of omeprazole
CA2166483A1 (en) New Pharmaceutical Formulation
DE69628444D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACIDABLE OMEPRAZOLE AND METHOD FOR THE PRODUCTION THEREOF
CA2147606A1 (en) Stable Extended Release Oral Dosage Composition
EP1123087A4 (en) Oral pulsed dose drug delivery system
YU49065B (en) OMEPRAZOLE ENANTIOMERS, PROCEDURE FOR THEIR PRODUCTION, PHARMACEUTICAL PRODUCTS, AND THEIR USE IN MEDICINE
CA2170647A1 (en) Multiple unit tableted dosage form i
DE69909316D1 (en) PHARMACEUTICAL FORMULATION WITH OMEPRAZOL
EE9700060A (en) 2-Aryl-substituted pyridines, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE9700153A (en) Heterocycle-fused pyridines, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
MX9604354A (en) New oral pharmaceutical dosage form.
AR005282A1 (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET OF MULTIPLE UNITS, USE OF THE SAME FOR THE PREPARATION OF MEDICINES, AND PROCEDURE FOR ITS MANUFACTURE.
EE9700043A (en) Substituted oxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
SE9402422D0 (en) New beads for controlled release and a pharmaceutical preparation containing the same
NO863997L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
ATE380022T1 (en) MULTIPARTICULAR MEDICINAL FORM CONTAINING AT LEAST TWO DIFFERENTLY COATED PELLET FORMS
DE59710629D1 (en) STABLE MEDICINE FORM WITH BENZIMIDAZOLE DERIVATIVES AS AN ACTIVE SUBSTANCE FOR ORAL ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF
NO20010277D0 (en) Benzocycloheptenes, process for their preparation, pharmaceutical preparations containing them, and their use in the manufacture of medicaments
NO934836D0 (en) Process for the preparation and use as a medicament or diagnostic of 2,4-substituted 5- (N-substituted-sulfamoyl) -benzoylgu anidines, and medicaments containing them
NO308527B1 (en) Substituted 2-naphthoylguanidines, their use in the manufacture of a medicament and medicaments and preparations containing the compounds
NO883986D0 (en) PROCEDURE FOR THE PREPARATION OF N- (SUBSTITUTED ALKYLIDE) -1,2,3,4-TETRAHYDRO-9 ACRIDINAMINES AND USE THEREOF AS MEDICINES.
IT8721540A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND THEIR THERAPEUTIC USE.
JO1880B1 (en) Multiple Unit Tableted Dosage Form I

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application